Brief: Medigene Says Co Plans To Reduce Share Capital & Amends Financial Guidance For 2024
13/05/2024 19:42
May 13 (Reuters) - Medigene AG MDG1k.DE :
* PLANS TO REDUCE SHARE CAPITAL AND AMENDS FINANCIAL
GUIDANCE FOR
2024
* COMPANY NOW EXPECTS TO EXTEND ITS CASH RUNWAY INTO JULY
2025
FROM PREVIOUSLY APRIL 2025.
* COMPANY MAINTAINS ITS GUIDANCE ON EXPECTED REVENUES TO BE
BETWEEN EUR 9 AND 11 MILLION (UNCHANGED) IN 2024
* RESEARCH AND DEVELOPMENT FOR FY COSTS WILL INCREASE FROM
PRIOR
ESTIMATES OF EUR 11-13 MILLION TO EUR 11.5-13.5 MILLION.
Source text for Eikon: ID:nPexkGybta
Further company coverage: MDG1k.DE
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medigene AG
See all newsBrief: Medigene Files Application For The Opening Of Insolvency Proceedings
Brief: Medigene Files Patent For Unique Nk-Specific TCR Construct With European Patent Office
Brief: Medigene AG Says Co Amends Financial Guidance For 2024
Brief: Medigene AG Expands Protection Of KRAS Library With Filing Of New Patent Application
Brief: Medigene H1 Revenue EUR 4.5 Million